Neumorgen Pharmaceuticals Private Limited
About Neumorgen Pharmaceuticals Private Limited
Data last updated:
Neumorgen Pharmaceuticals Private Limited is a private limited company based in Sahibabad, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 25 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC108375. Its GSTIN is 09AAGCN2109J1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajendra Prasad Gupta and Vishal Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 733/B – 4 Moon Star Apartment Shalimar Garden Extension, Sahibabad, Uttar Pradesh, India – 201005.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.37 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹47,078 (net margin 0.8%) and EBITDA of ₹67,758 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 45% over five years.
Company details
Contact details
Neumorgen Pharmaceuticals Private Limited's registered office is in Sahibabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address733/B – 4 Moon Star Apartment Shalimar Garden Extension, Sahibabad, Uttar Pradesh, India – 201005
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Neumorgen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neumorgen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neumorgen Pharmaceuticals Private Limited, buy the company report.
Financials of Neumorgen Pharmaceuticals Private Limited
FY 2025 filings availableNeumorgen Pharmaceuticals Private Limited reported revenue of ₹57.37 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 48% growth in the latest year. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67,758 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47,078 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neumorgen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neumorgen Pharmaceuticals Private Limited
Neumorgen Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Prasad Gupta | Director | 28 Feb 2022 | 4 Years 8 Months | Current |
| Vishal Gupta | Director | 25 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Neumorgen Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kube Pharmaceuticals Private Limited | ₹57.79 Lakh (FY 2025) | 56.0% | Nagpur, Maharashtra, India | |||
| Zatix Pharmaceuticals Private Limited | ₹57.7 Lakh (FY 2024) | 46.0% | New Delhi, Delhi, India | |||
| Ramsar Pharmaceuticals Private Limited | ₹57.52 Lakh (FY 2025) | 2273.0% | Bhubaneswar, Odisha, India | |||
| Neumorgen Pharmaceuticals Private Limitedthis company | ₹57.37 Lakh (FY 2025) | ₹47,078 | 0.8% | 48.0% | Sahibabad, Uttar Pradesh, India | |
| Aveza Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | 34.0% | Jaipur, Rajasthan, India | |||
| Novostar Pharmaceuticals Private Limited | ₹57.22 Lakh (FY 2025) | 119.0% | Ambala, Haryana, India | |||
| Capricon Pharmaceuticals Private Limited | ₹57.19 Lakh (FY 2018) | -59.0% | New Delhi, Delhi, India |
To see the full peer comparison of Neumorgen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neumorgen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neumorgen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neumorgen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN2109J1ZG | Uttar Pradesh | Active | 03 Dec 2018 |
To see the full GST registrations and return filing status of Neumorgen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neumorgen Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Preeti Gupta ceased to be Director on 28 Feb 2022.
Frequently asked questions
Neumorgen Pharmaceuticals is an active private limited company based in Sahibabad, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 25 September 2018 (8+ years old) and is registered under CIN U74999UP2018PTC108375.
Neumorgen Pharmaceuticals has 2 current directors:
- Rajendra Prasad Gupta - Director
- Vishal Gupta - Director
The latest financial statements of Neumorgen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Neumorgen Pharmaceuticals is 09AAGCN2109J1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Neumorgen Pharmaceuticals is U74999UP2018PTC108375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neumorgen Pharmaceuticals was incorporated on 25 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Neumorgen Pharmaceuticals by revenue are Kube Pharmaceuticals Private Limited, Zatix Pharmaceuticals Private Limited, Ramsar Pharmaceuticals Private Limited, Aveza Pharmaceuticals Private Limited, Novostar Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Preeti Gupta ceased to be Director on 28 Feb 2022. Rajendra Prasad Gupta was appointed as Director on 28 Feb 2022. Vishal Gupta was appointed as Director on 25 Sep 2018.
The registered office of Neumorgen Pharmaceuticals is at 733B – 4 Moon Star Apartment Shalimar Garden Extension, Sahibabad, Uttar Pradesh, India – 201005.
Neumorgen Pharmaceuticals operates in the business services industry, in the other services segment.
Neumorgen Pharmaceuticals can be reached at its registered office: 733B – 4 Moon Star Apartment Shalimar Garden Extension, Sahibabad, Uttar Pradesh, India – 201005.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
